| 1 | COGT | Cogent Biosciences, Inc. | 10.09% |
| 2 | LIVN | LivaNova PLC | 6.48% |
| 3 | TVTX | Travere Therapeutics, Inc. | 5.49% |
| 4 | GH | Guardant Health, Inc. | 5.39% |
| 5 | TMDX | TransMedics Group, Inc. | 5.19% |
| 6 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.32% |
| 7 | BBIO | BridgeBio Pharma, Inc. | 4.02% |
| 8 | SVRA | Savara Inc. | 3.39% |
| 9 | CORT | Corcept Therapeutics Incorporated | 3.34% |
| 10 | NKTR | Nektar Therapeutics | 3.11% |
| 11 | UTHR | United Therapeutics Corporation | 3.07% |
| 12 | KALV | KalVista Pharmaceuticals, Inc. | 3.05% |
| 13 | SYRE | Spyre Therapeutics, Inc. | 2.94% |
| 14 | RDNT | RadNet, Inc. | 2.88% |
| 15 | WVE | Wave Life Sciences Ltd. | 2.73% |
| 16 | INSM | Insmed Incorporated | 2.67% |
| 17 | ICUI | ICU Medical, Inc. | 2.65% |
| 18 | MIRM | Mirum Pharmaceuticals, Inc. | 2.47% |
| 19 | TRVI | Trevi Therapeutics, Inc. | 2.43% |
| 20 | RARE | Ultragenyx Pharmaceutical Inc. | 2.39% |
| 21 | ACAD | ACADIA Pharmaceuticals Inc. | 2.38% |
| 22 | COLL | Collegium Pharmaceutical, Inc. | 2.21% |
| 23 | ATEC | Alphatec Holdings, Inc. | 2.21% |
| 24 | AXSM | Axsome Therapeutics, Inc. | 1.94% |
| 25 | CBLL | CeriBell, Inc. | 1.55% |
| View LFSC holdings |
